The ambulatory EHR market would grow at a CAGR of 5.76% over the predicted time frame. The market is expected to increase in value from US$ 6.13 Bn in 2022 to US$ 9.6 Bn in 2030.
The on ambulatory EHR Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.
Download Free Sample@ https://www.precedenceresearch.com/sample/2311
A recent report provides crucial insights along with application based and forecast information in the Global Ambulatory EHR Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Ambulatory EHR market.
A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.
Companies and Manufacturers Covered
The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Ambulatory EHR market are included as given below:
Ambulatory EHR Market Key Players
- AdvancedMD, Inc. (U.S.).
- Allscripts Healthcare Solutions, Inc. (US)
- Amazing Charts, LLC (The U.S),
- Athenahealth (The U.S),
- CareCloud, Inc. (The U.S),
- Cerner Corporation (US)
- Computer Programs and Systems, Inc. (US)
- CureMD Healthcare (The U.S),
- DrChrono (The U.S),
- eClinicalWorks (The U.S),
- eMDs, Inc.
- Epic Systems Corporation (US)
- General Electric Company
- Greenway Health, LLC (The U.S),
- Healthland
- Kareo (The U.S),
- McKesson Corporation
- Medical Information Technology, Inc. (US)
- Medical Transcription Billing Corporation
- Modernizing Medicine, Inc.
- Netsmart Technologies (The U.S),
- Nextgen Healthcare Information Systems LLC
- Practice Fusion Inc.
- QSI Management, LLC
Market Segments
By Deployment Mode
- Cloud/Web-based
- On-premise
By Type
- All-in-one
- Modular
By Practice Size
- Large Practices
- Small-to-medium-sized Practices
- Solo Practices
By Application
- Practice Management
- Patient Portals
- Computerized Physician Order Entry (CPOE)
- Clinical Decision Support (CDS)
- Population Health Management
- Referral Management
- Other Applications
By End User
- Hospital-owned Ambulatory Centres
- Independent Ambulatory Centres
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
Report Objectives
- To define, describe, and forecast the global ambulatory EHR market based on product, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the ambulatory EHR market
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Ambulatory EHR Market
5.1. COVID-19 Landscape: Ambulatory EHR Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Ambulatory EHR Market, By Deployment Mode
8.1. Ambulatory EHR Market, by Deployment Mode, 2022-2030
8.1.1. Cloud/Web-based
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. On-premise
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Ambulatory EHR Market, By Type
9.1. Ambulatory EHR Market, by Type, 2022-2030
9.1.1. All-in-one
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Modular
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Ambulatory EHR Market, By Practice Size
10.1. Ambulatory EHR Market, by Practice Size, 2022-2030
10.1.1. Large Practices
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Small-to-medium-sized Practices
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Solo Practices
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Ambulatory EHR Market, By Application
11.1. Ambulatory EHR Market, by Application, 2022-2030
11.1.1. Practice Management
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Patient Portals
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Computerized Physician Order Entry (CPOE)
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Clinical Decision Support (CDS)
11.1.4.1. Market Revenue and Forecast (2017-2030)
11.1.5. Population Health Management
11.1.5.1. Market Revenue and Forecast (2017-2030)
11.1.6. Referral Management
11.1.6.1. Market Revenue and Forecast (2017-2030)
11.1.7. Others
11.1.7.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Ambulatory EHR Market, By End User
12.1. Ambulatory EHR Market, by End User, 2022-2030
12.1.1. Hospital-owned Ambulatory Centres
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Independent Ambulatory Centres
12.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Ambulatory EHR Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)
13.1.2. Market Revenue and Forecast, by Type (2017-2030)
13.1.3. Market Revenue and Forecast, by Practice Size (2017-2030)
13.1.4. Market Revenue and Forecast, by Application (2017-2030)
13.1.5. Market Revenue and Forecast, by End User (2017-2030)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)
13.1.6.2. Market Revenue and Forecast, by Type (2017-2030)
13.1.6.3. Market Revenue and Forecast, by Practice Size (2017-2030)
13.1.6.4. Market Revenue and Forecast, by Application (2017-2030)
13.1.6.5. Market Revenue and Forecast, by End User (2017-2030)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)
13.1.7.2. Market Revenue and Forecast, by Type (2017-2030)
13.1.7.3. Market Revenue and Forecast, by Practice Size (2017-2030)
13.1.7.4. Market Revenue and Forecast, by Application (2017-2030)
13.1.7.5. Market Revenue and Forecast, by End User (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)
13.2.2. Market Revenue and Forecast, by Type (2017-2030)
13.2.3. Market Revenue and Forecast, by Practice Size (2017-2030)
13.2.4. Market Revenue and Forecast, by Application (2017-2030)
13.2.5. Market Revenue and Forecast, by End User (2017-2030)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)
13.2.6.2. Market Revenue and Forecast, by Type (2017-2030)
13.2.6.3. Market Revenue and Forecast, by Practice Size (2017-2030)
13.2.7. Market Revenue and Forecast, by Application (2017-2030)
13.2.8. Market Revenue and Forecast, by End User (2017-2030)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)
13.2.9.2. Market Revenue and Forecast, by Type (2017-2030)
13.2.9.3. Market Revenue and Forecast, by Practice Size (2017-2030)
13.2.10. Market Revenue and Forecast, by Application (2017-2030)
13.2.11. Market Revenue and Forecast, by End User (2017-2030)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)
13.2.12.2. Market Revenue and Forecast, by Type (2017-2030)
13.2.12.3. Market Revenue and Forecast, by Practice Size (2017-2030)
13.2.12.4. Market Revenue and Forecast, by Application (2017-2030)
13.2.13. Market Revenue and Forecast, by End User (2017-2030)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)
13.2.14.2. Market Revenue and Forecast, by Type (2017-2030)
13.2.14.3. Market Revenue and Forecast, by Practice Size (2017-2030)
13.2.14.4. Market Revenue and Forecast, by Application (2017-2030)
13.2.15. Market Revenue and Forecast, by End User (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)
13.3.2. Market Revenue and Forecast, by Type (2017-2030)
13.3.3. Market Revenue and Forecast, by Practice Size (2017-2030)
13.3.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.5. Market Revenue and Forecast, by End User (2017-2030)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)
13.3.6.2. Market Revenue and Forecast, by Type (2017-2030)
13.3.6.3. Market Revenue and Forecast, by Practice Size (2017-2030)
13.3.6.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.7. Market Revenue and Forecast, by End User (2017-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)
13.3.8.2. Market Revenue and Forecast, by Type (2017-2030)
13.3.8.3. Market Revenue and Forecast, by Practice Size (2017-2030)
13.3.8.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.9. Market Revenue and Forecast, by End User (2017-2030)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)
13.3.10.2. Market Revenue and Forecast, by Type (2017-2030)
13.3.10.3. Market Revenue and Forecast, by Practice Size (2017-2030)
13.3.10.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.10.5. Market Revenue and Forecast, by End User (2017-2030)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)
13.3.11.2. Market Revenue and Forecast, by Type (2017-2030)
13.3.11.3. Market Revenue and Forecast, by Practice Size (2017-2030)
13.3.11.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.11.5. Market Revenue and Forecast, by End User (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)
13.4.2. Market Revenue and Forecast, by Type (2017-2030)
13.4.3. Market Revenue and Forecast, by Practice Size (2017-2030)
13.4.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.5. Market Revenue and Forecast, by End User (2017-2030)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)
13.4.6.2. Market Revenue and Forecast, by Type (2017-2030)
13.4.6.3. Market Revenue and Forecast, by Practice Size (2017-2030)
13.4.6.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.7. Market Revenue and Forecast, by End User (2017-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)
13.4.8.2. Market Revenue and Forecast, by Type (2017-2030)
13.4.8.3. Market Revenue and Forecast, by Practice Size (2017-2030)
13.4.8.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.9. Market Revenue and Forecast, by End User (2017-2030)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)
13.4.10.2. Market Revenue and Forecast, by Type (2017-2030)
13.4.10.3. Market Revenue and Forecast, by Practice Size (2017-2030)
13.4.10.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.10.5. Market Revenue and Forecast, by End User (2017-2030)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)
13.4.11.2. Market Revenue and Forecast, by Type (2017-2030)
13.4.11.3. Market Revenue and Forecast, by Practice Size (2017-2030)
13.4.11.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.11.5. Market Revenue and Forecast, by End User (2017-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)
13.5.2. Market Revenue and Forecast, by Type (2017-2030)
13.5.3. Market Revenue and Forecast, by Practice Size (2017-2030)
13.5.4. Market Revenue and Forecast, by Application (2017-2030)
13.5.5. Market Revenue and Forecast, by End User (2017-2030)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)
13.5.6.2. Market Revenue and Forecast, by Type (2017-2030)
13.5.6.3. Market Revenue and Forecast, by Practice Size (2017-2030)
13.5.6.4. Market Revenue and Forecast, by Application (2017-2030)
13.5.7. Market Revenue and Forecast, by End User (2017-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Deployment Mode (2017-2030)
13.5.8.2. Market Revenue and Forecast, by Type (2017-2030)
13.5.8.3. Market Revenue and Forecast, by Practice Size (2017-2030)
13.5.8.4. Market Revenue and Forecast, by Application (2017-2030)
13.5.8.5. Market Revenue and Forecast, by End User (2017-2030)
Chapter 14. Company Profiles
14.1. AdvancedMD, Inc. (U.S.)
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Allscripts Healthcare Solutions, Inc. (US)
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Amazing Charts, LLC (The U.S)
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Athenahealth (The U.S)
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. CareCloud, Inc. (The U.S)
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Cerner Corporation (US)
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Computer Programs and Systems, Inc. (US)
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. CureMD Healthcare (The U.S)
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. DrChrono (The U.S)
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. eClinicalWorks (The U.S)
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 Comments